Your browser doesn't support javascript.
loading
Impaired antibody response to COVID-19 vaccination in patients with chronic myeloid neoplasms.
Chowdhury, Onima; Bruguier, Hannah; Mallett, Garry; Sousos, Nikolaos; Crozier, Kirsty; Allman, Caroline; Eyre, David; Lumley, Sheila; Strickland, Marie; Karali, Christina S; Murphy, Lauren; Sternberg, Alex; Jeffery, Katie; Mead, Adam J; Peniket, Andy; Psaila, Bethan.
Afiliação
  • Chowdhury O; MRC Molecular Haematology Unit, MRC Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, UK.
  • Bruguier H; National Institute of Health Research Oxford Biomedical Research Centre, Oxford, UK.
  • Mallett G; Department of Haematology, Churchill Hospital, Oxford University Hospitals' NHS Foundation Trust, Oxford, UK.
  • Sousos N; Department of Haematology, Churchill Hospital, Oxford University Hospitals' NHS Foundation Trust, Oxford, UK.
  • Crozier K; Department of Haematology, Churchill Hospital, Oxford University Hospitals' NHS Foundation Trust, Oxford, UK.
  • Allman C; MRC Molecular Haematology Unit, MRC Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, UK.
  • Eyre D; National Institute of Health Research Oxford Biomedical Research Centre, Oxford, UK.
  • Lumley S; Department of Haematology, Churchill Hospital, Oxford University Hospitals' NHS Foundation Trust, Oxford, UK.
  • Strickland M; Department of Haematology, Churchill Hospital, Oxford University Hospitals' NHS Foundation Trust, Oxford, UK.
  • Karali CS; Department of Haematology, Churchill Hospital, Oxford University Hospitals' NHS Foundation Trust, Oxford, UK.
  • Murphy L; Nuffield Department of Population Health, Big Data Institute, University of Oxford, Oxford, UK.
  • Sternberg A; Department of Microbiology, Oxford University Hospitals' NHS Foundation Trust, Oxford, UK.
  • Jeffery K; Department of Microbiology, Oxford University Hospitals' NHS Foundation Trust, Oxford, UK.
  • Mead AJ; Nuffield Department of Medicine, University of Oxford, Oxford, UK.
  • Peniket A; MRC Molecular Haematology Unit, MRC Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, UK.
  • Psaila B; National Institute of Health Research Oxford Biomedical Research Centre, Oxford, UK.
Br J Haematol ; 194(6): 1010-1015, 2021 09.
Article em En | MEDLINE | ID: mdl-34132395

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Leucemia Mielogênica Crônica BCR-ABL Positiva / Vacinação / Vacinas contra COVID-19 / SARS-CoV-2 / COVID-19 / Formação de Anticorpos Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Br J Haematol Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Reino Unido

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Leucemia Mielogênica Crônica BCR-ABL Positiva / Vacinação / Vacinas contra COVID-19 / SARS-CoV-2 / COVID-19 / Formação de Anticorpos Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Br J Haematol Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Reino Unido